MA38169A1 - Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux - Google Patents
Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevauxInfo
- Publication number
- MA38169A1 MA38169A1 MA38169A MA38169A MA38169A1 MA 38169 A1 MA38169 A1 MA 38169A1 MA 38169 A MA38169 A MA 38169A MA 38169 A MA38169 A MA 38169A MA 38169 A1 MA38169 A1 MA 38169A1
- Authority
- MA
- Morocco
- Prior art keywords
- ciclesonide
- horses
- treatment
- respiratory tract
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne le domaine de la médecine, en particulier le domaine de la médecine vétérinaire. La présente invention concerne des glucocorticoïdes, en particulier le ciclésonide ou un dérivé pharmaceutiquement acceptable de celui-ci, pour le traitement d'une maladie des voies respiratoires chez les chevaux, telles qu'une maladie pulmonaire, de préférence l'obstruction récurrente des voies respiratoires (rao), la maladie pulmonaire obstructive associée aux pâturages d'été (spaopd), et une maladie inflammatoire des voies respiratoires (iad).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12199302 | 2012-12-21 | ||
PCT/EP2013/077265 WO2014096115A1 (fr) | 2012-12-21 | 2013-12-18 | Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux |
Publications (2)
Publication Number | Publication Date |
---|---|
MA38169A1 true MA38169A1 (fr) | 2017-01-31 |
MA38169B2 MA38169B2 (fr) | 2021-08-31 |
Family
ID=47552829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA38169A MA38169B2 (fr) | 2012-12-21 | 2013-12-18 | Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux |
Country Status (24)
Country | Link |
---|---|
US (4) | US9918995B2 (fr) |
EP (1) | EP2934479B1 (fr) |
AR (1) | AR094241A1 (fr) |
AU (2) | AU2013360691B2 (fr) |
BR (2) | BR112015010842B1 (fr) |
CA (1) | CA2888428C (fr) |
CY (2) | CY1121115T1 (fr) |
DK (1) | DK2934479T3 (fr) |
ES (1) | ES2693779T3 (fr) |
FR (1) | FR20C1026I1 (fr) |
HR (1) | HRP20181980T1 (fr) |
HU (1) | HUS2000020I1 (fr) |
IN (1) | IN2015DN02894A (fr) |
LT (2) | LT2934479T (fr) |
MA (1) | MA38169B2 (fr) |
MX (1) | MX368306B (fr) |
NO (1) | NO2020014I1 (fr) |
NZ (1) | NZ706573A (fr) |
PL (1) | PL2934479T3 (fr) |
PT (1) | PT2934479T (fr) |
RS (1) | RS57740B1 (fr) |
SI (1) | SI2934479T1 (fr) |
WO (1) | WO2014096115A1 (fr) |
ZA (1) | ZA201502288B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140057604A (ko) | 2011-08-12 | 2014-05-13 | 베링거잉겔하임베트메디카게엠베하 | 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제 |
CA2888428C (fr) | 2012-12-21 | 2021-07-13 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide pour le traitement d'une maladie des voies respiratoires chez les chevaux |
DK2934544T3 (en) | 2012-12-21 | 2019-03-04 | Boehringer Ingelheim Vetmedica Gmbh | PHARMACEUTICAL FORMULA INCLUDING CICLESONID |
ES2759247T3 (es) | 2014-06-18 | 2020-05-08 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos |
WO2018070819A1 (fr) * | 2016-10-14 | 2018-04-19 | 제주대학교 산학협력단 | Composition comprenant du ciclésonide destinée à inhiber la croissance de cellules souches cancéreuses |
EP4087581A1 (fr) | 2020-01-10 | 2022-11-16 | Boehringer Ingelheim Vetmedica GmbH | Ciclésonide pour améliorer la qualité de vie (qol) chez les équidés |
CA3186956A1 (fr) | 2020-07-31 | 2022-02-03 | Chemo Research , S.L. | Polytherapie destinee a une administration par inhalation |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5954049A (en) | 1991-10-15 | 1999-09-21 | Trudell Medical Limited | Equine mask with MDI adapter |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
US6706726B2 (en) | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
DE10050994A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
DE10062712A1 (de) | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
US6904908B2 (en) | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
DE10237739A1 (de) | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
US20040053902A1 (en) | 2002-09-13 | 2004-03-18 | Smith C. Steven | Novel composition and method for treatment of upper respiratory conditions |
US20060293293A1 (en) * | 2003-05-22 | 2006-12-28 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
US20050020692A1 (en) | 2003-07-24 | 2005-01-27 | Ciofalo Vincent B. | Treatment of heaves |
ES2452691T5 (es) | 2003-09-16 | 2022-09-14 | Covis Pharma Gmbh | Uso de ciclesonida para el tratamiento de enfermedades respiratorias |
PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
JP2007533706A (ja) | 2004-04-20 | 2007-11-22 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用 |
JP2008504341A (ja) | 2004-06-29 | 2008-02-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ステロイドと抗コリン作用剤とを含む吸入用薬剤 |
DE102004056579A1 (de) | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid |
UY30543A1 (es) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
UY30542A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
WO2010149280A1 (fr) | 2009-06-25 | 2010-12-29 | Boehringer Ingelheim Vetmedica Gmbh | Inhalateur |
US7829748B1 (en) * | 2009-09-21 | 2010-11-09 | Honeywell International Inc. | Process for the manufacture of 1,3,3,3-tetrafluoropropene |
US20150202148A1 (en) | 2012-07-05 | 2015-07-23 | Arven llac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose |
US20150202297A1 (en) | 2012-07-05 | 2015-07-23 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose and a ternary component |
US9539408B2 (en) | 2012-10-31 | 2017-01-10 | Trudell Medical International | Nebulizer apparatus |
DK2934544T3 (en) | 2012-12-21 | 2019-03-04 | Boehringer Ingelheim Vetmedica Gmbh | PHARMACEUTICAL FORMULA INCLUDING CICLESONID |
CA2888428C (fr) | 2012-12-21 | 2021-07-13 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide pour le traitement d'une maladie des voies respiratoires chez les chevaux |
PT3035886T (pt) | 2013-08-20 | 2021-01-04 | Boehringer Ingelheim Vetmedica Gmbh | Nalador |
RS60034B1 (sr) | 2013-08-20 | 2020-04-30 | Boehringer Ingelheim Vetmedica Gmbh | Inhalator |
ES2759247T3 (es) | 2014-06-18 | 2020-05-08 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos |
-
2013
- 2013-12-18 CA CA2888428A patent/CA2888428C/fr active Active
- 2013-12-18 MA MA38169A patent/MA38169B2/fr unknown
- 2013-12-18 WO PCT/EP2013/077265 patent/WO2014096115A1/fr active Application Filing
- 2013-12-18 RS RS20181190A patent/RS57740B1/sr unknown
- 2013-12-18 MX MX2015007947A patent/MX368306B/es active IP Right Grant
- 2013-12-18 LT LTEP13811924.3T patent/LT2934479T/lt unknown
- 2013-12-18 BR BR112015010842-3A patent/BR112015010842B1/pt active IP Right Grant
- 2013-12-18 NZ NZ70657313A patent/NZ706573A/en unknown
- 2013-12-18 SI SI201331266T patent/SI2934479T1/sl unknown
- 2013-12-18 PT PT13811924T patent/PT2934479T/pt unknown
- 2013-12-18 PL PL13811924T patent/PL2934479T3/pl unknown
- 2013-12-18 EP EP13811924.3A patent/EP2934479B1/fr active Active
- 2013-12-18 BR BR122016029247-9A patent/BR122016029247A2/pt not_active Application Discontinuation
- 2013-12-18 AU AU2013360691A patent/AU2013360691B2/en active Active
- 2013-12-18 ES ES13811924.3T patent/ES2693779T3/es active Active
- 2013-12-18 IN IN2894DEN2015 patent/IN2015DN02894A/en unknown
- 2013-12-18 US US14/654,009 patent/US9918995B2/en active Active
- 2013-12-18 DK DK13811924.3T patent/DK2934479T3/en active
- 2013-12-18 US US14/132,580 patent/US20140179651A1/en not_active Abandoned
- 2013-12-20 AR ARP130104978A patent/AR094241A1/es not_active Application Discontinuation
-
2015
- 2015-04-07 ZA ZA2015/02288A patent/ZA201502288B/en unknown
-
2016
- 2016-10-13 US US15/292,765 patent/US10258634B2/en active Active
-
2018
- 2018-02-06 US US15/889,307 patent/US10441597B2/en active Active
- 2018-03-07 AU AU2018201642A patent/AU2018201642B2/en active Active
- 2018-11-09 CY CY181101189T patent/CY1121115T1/el unknown
- 2018-11-26 HR HRP20181980TT patent/HRP20181980T1/hr unknown
-
2020
- 2020-06-12 NO NO2020014C patent/NO2020014I1/no unknown
- 2020-06-18 LT LTPA2020511C patent/LTPA2020511I1/lt unknown
- 2020-06-26 FR FR20C1026C patent/FR20C1026I1/fr active Active
- 2020-06-29 CY CY2020015C patent/CY2020015I2/el unknown
- 2020-06-29 HU HUS2000020C patent/HUS2000020I1/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA38169A1 (fr) | Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux | |
EA031157B9 (ru) | Вводимая перорально кортикостероидная композиция | |
FI3626725T3 (fi) | Kolaanijohdannaisia käytettäväksi FXR:n ja TGR5:n/GPBAR1:n välittämien sairauksien hoidossa ja/tai ennaltaehkäisyssä | |
EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
EA201290519A1 (ru) | Положительные аллостерические модуляторы рецептора хинолин амида m1 | |
MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
EP2582676A4 (fr) | Modulateurs allostériques positifs du récepteur m1 de l'amide tétrahydroquinoline | |
NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
EA201491606A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
MX2019014935A (es) | Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. | |
PH12016500746A1 (en) | A novel formulation of meloxicam | |
EA200802020A1 (ru) | Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1 | |
TW201613591A (en) | Pharmaceutical compositions comprising a DEXTROMETHORPHAN compound and QUINIDINE for the treatment of agitation in dementia | |
EA201001781A1 (ru) | Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов | |
EA201390070A1 (ru) | Лечение расстройств, вызванных l-dopa, дофаминовым агонистом и/или усилителем дофамина | |
RU2016132762A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
WO2009134668A3 (fr) | Modulateurs allostériques positifs pour le récepteur m1 de 4-oxo-1,4-dihydroquinoléine | |
MY182553A (en) | Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | |
PH12015502560A1 (en) | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease | |
PH12016501119A1 (en) | Zirconium silicate for treating hyperkalemia without co-administering lithium | |
FR2927256B1 (fr) | Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation | |
FR2960780B1 (fr) | Medicament pour le traitement de la maladie de parkinson | |
Wollin et al. | PI3kinase Gamma Kinase Dead Knock-In Mice Are Protected Against Cigarette Smoke-Induced Pulmonary Inflammation | |
ATE522537T1 (de) | (e)-n-ä3-ä1-(8-fluor-11h-10-oxa-1-aza-dibenzo-ä , dü-cyclohepten-5-yliden)-propylü-phenylü- methylsulfon-amid als glucocorticoid- rezeptormodulator zur behandlung rheumatoider arthritis | |
JO2919B1 (en) | Aryl methyl benzocoinazolinone M1 positive allosteric modulation receptor |